Process for the preparation of epoprostenol sodium of enhanced stability
The present invention provides stable epoprostenol sodium drug substance which can be stored in deep freezer (-20 ± 5 DEG C) for at least 3 years, characterized by that the lyophilized drug substance contains epoprostenol sodium salt and, related to the amount of the epoprostenol sodium salt, it con...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TORMASI, ROBERTNE KARDOS, ZSUZSANNA MOLNAR, JOZSEF HORTOBAGYI, IREN TAKACS, LASZLO LASZLOFI, ISTVAN |
description | The present invention provides stable epoprostenol sodium drug substance which can be stored in deep freezer (-20 ± 5 DEG C) for at least 3 years, characterized by that the lyophilized drug substance contains epoprostenol sodium salt and, related to the amount of the epoprostenol sodium salt, it contains in 3-7.5 mass% inorganic base or basic-hydrolyzing inorganic salt. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW201808303A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW201808303A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW201808303A3</originalsourceid><addsrcrecordid>eNqNjDEKAjEQANNYiPqH9QFCNM21IsqVFgeWx5rbcIGYXbJr4e8V8QFWA8MwS9dfG0dShcQNbCaQRoINLXMFTkDC0liNKhdQnvLz8dV1xhppAjW855LttXaLhEVp8-PKbS_n4dTvPoeRVDBSJRuH28HvO98FH47hn-YN4oM08Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Process for the preparation of epoprostenol sodium of enhanced stability</title><source>esp@cenet</source><creator>TORMASI, ROBERTNE ; KARDOS, ZSUZSANNA ; MOLNAR, JOZSEF ; HORTOBAGYI, IREN ; TAKACS, LASZLO ; LASZLOFI, ISTVAN</creator><creatorcontrib>TORMASI, ROBERTNE ; KARDOS, ZSUZSANNA ; MOLNAR, JOZSEF ; HORTOBAGYI, IREN ; TAKACS, LASZLO ; LASZLOFI, ISTVAN</creatorcontrib><description>The present invention provides stable epoprostenol sodium drug substance which can be stored in deep freezer (-20 ± 5 DEG C) for at least 3 years, characterized by that the lyophilized drug substance contains epoprostenol sodium salt and, related to the amount of the epoprostenol sodium salt, it contains in 3-7.5 mass% inorganic base or basic-hydrolyzing inorganic salt.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180316&DB=EPODOC&CC=TW&NR=201808303A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180316&DB=EPODOC&CC=TW&NR=201808303A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TORMASI, ROBERTNE</creatorcontrib><creatorcontrib>KARDOS, ZSUZSANNA</creatorcontrib><creatorcontrib>MOLNAR, JOZSEF</creatorcontrib><creatorcontrib>HORTOBAGYI, IREN</creatorcontrib><creatorcontrib>TAKACS, LASZLO</creatorcontrib><creatorcontrib>LASZLOFI, ISTVAN</creatorcontrib><title>Process for the preparation of epoprostenol sodium of enhanced stability</title><description>The present invention provides stable epoprostenol sodium drug substance which can be stored in deep freezer (-20 ± 5 DEG C) for at least 3 years, characterized by that the lyophilized drug substance contains epoprostenol sodium salt and, related to the amount of the epoprostenol sodium salt, it contains in 3-7.5 mass% inorganic base or basic-hydrolyzing inorganic salt.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKAjEQANNYiPqH9QFCNM21IsqVFgeWx5rbcIGYXbJr4e8V8QFWA8MwS9dfG0dShcQNbCaQRoINLXMFTkDC0liNKhdQnvLz8dV1xhppAjW855LttXaLhEVp8-PKbS_n4dTvPoeRVDBSJRuH28HvO98FH47hn-YN4oM08Q</recordid><startdate>20180316</startdate><enddate>20180316</enddate><creator>TORMASI, ROBERTNE</creator><creator>KARDOS, ZSUZSANNA</creator><creator>MOLNAR, JOZSEF</creator><creator>HORTOBAGYI, IREN</creator><creator>TAKACS, LASZLO</creator><creator>LASZLOFI, ISTVAN</creator><scope>EVB</scope></search><sort><creationdate>20180316</creationdate><title>Process for the preparation of epoprostenol sodium of enhanced stability</title><author>TORMASI, ROBERTNE ; KARDOS, ZSUZSANNA ; MOLNAR, JOZSEF ; HORTOBAGYI, IREN ; TAKACS, LASZLO ; LASZLOFI, ISTVAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW201808303A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>TORMASI, ROBERTNE</creatorcontrib><creatorcontrib>KARDOS, ZSUZSANNA</creatorcontrib><creatorcontrib>MOLNAR, JOZSEF</creatorcontrib><creatorcontrib>HORTOBAGYI, IREN</creatorcontrib><creatorcontrib>TAKACS, LASZLO</creatorcontrib><creatorcontrib>LASZLOFI, ISTVAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TORMASI, ROBERTNE</au><au>KARDOS, ZSUZSANNA</au><au>MOLNAR, JOZSEF</au><au>HORTOBAGYI, IREN</au><au>TAKACS, LASZLO</au><au>LASZLOFI, ISTVAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Process for the preparation of epoprostenol sodium of enhanced stability</title><date>2018-03-16</date><risdate>2018</risdate><abstract>The present invention provides stable epoprostenol sodium drug substance which can be stored in deep freezer (-20 ± 5 DEG C) for at least 3 years, characterized by that the lyophilized drug substance contains epoprostenol sodium salt and, related to the amount of the epoprostenol sodium salt, it contains in 3-7.5 mass% inorganic base or basic-hydrolyzing inorganic salt.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_TW201808303A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Process for the preparation of epoprostenol sodium of enhanced stability |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T23%3A01%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TORMASI,%20ROBERTNE&rft.date=2018-03-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW201808303A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |